Santé Active Edition – Synergy Pharm: Medical Writing Solutions
We have been serving the pharmaceutical industry, and more generally the scientific research community, for more than 30 years.
Every member of our team is an experienced medical writer with a PhD, and all are native English or French speakers with bilingual proficiency in French and English. We design and write medical marketing documents intended for the scientific community, healthcare professionals or the general public, as well as all the regulatory and clinical documentation required at the various stages of drug development, regardless of the therapeutic area. We also provide an editorial assistance service to support you in the publication of your research: from the correction of your article to its submission, and the drafting of responses to reviewers.
We work accurately and efficiently to meet your deadlines, while our compliance with international standards (CONSORT, ICH, etc.), systematic proofreading between medical writers, and attention to detail guarantee that your documents will be of the highest quality. Our adaptability and responsiveness lead us to develop privileged and ongoing relationships with our clients.
Each project is unique, and our team at Santé Active Edition-Synergy Pharm are on hand to adapt and respond to your requirements. Do not hesitate to contact us to discuss your needs, we are looking forward to assisting you with your projects!
Our latest news
World Diabetes Day 2022
Diabetes: a major global health issue
Diabetes (Diabetes Mellitus) is a chronic metabolic disease characterized by high levels of glucose in the blood due to deficient production of insulin by the pancreas or ineffective tissue responses to insulin.
It is one of the most rapidly growing global health emergencies, with the latest figures from the International Diabetes Federation (IDF) Atlas indicating that 10.5% of the world’s population (around 537 million people aged 20–79 years) are currently living with diabetes. This number is predicted to rise to 643 million (11.3%) by 2030 and to 783 million (12.2%) by 2045.
Read more
Publication about a new formulation for morphine sulfate
Decreasing moderate-to-severe pain using an opioid, a fine-tuning process
Morphine sulfate is a well-established first-line opioid used to treat moderate-to-severe pain. In adults and adolescents with cancer pain, the World Health Organization (WHO) recommends reducing pain to a level that allows patients to have an acceptable quality of life.
Read more
Publication about a new facial rosacea skin care product
Rosacea: a skin disease of the face that affects the quality of life of patients
Rosacea is a chronic and progressive dermatological disease that manifests as centrofacial erythema and tends to worsen over time. The two most common forms of rosacea (vascular and papulopustular) mainly affect women aged 30 to 50 years. Although it is more easily diagnosed in patients with fair skin, rosacea affects all skin types.
Read more